Skip to main content
Premium Trial:

Request an Annual Quote

Support for Another

In a briefing document, the US Food and Drug Administration says the SARS-CoV-2 vaccine from Johnson & Johnson meets the requirements to receive an Emergency Use Authorization, according to CNN.

J&J announced clinical trial results in January that said its vaccine had a 66 percent efficacy rate in preventing moderate-to-severe COVID-19. The company then said it would be seeking an EUA from the FDA.

A committee is to meet Friday to recommend whether or not the agency should authorize the vaccine, CNN notes. This means the FDA could make a decision as early as the weeking, the Washington Post says, noting that the agency previously, for the Pfizer/BioNTech and Moderna vaccines, FDA quickly greenlit the vaccines following the committee's recommendation.

The Post adds that public health officials have been awaiting the J&J vaccine, as it is a one-dose regimen and can be stored for months in a refrigerator. It further adds that though the vaccine had a lower efficacy rate in South Africa where a viral variant has taken hold, it still had high efficacy in preventing severe disease there.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.